ABSTRACT The incorporation of iron into human cells involves the binding of diferric transferrin to a specific cell surface receptor. We studied the process of endocytosis in K562, a human erythroid cell line, by using tetramethylrhodamine isothiocyanate-labeled transferrin (TRITC-transferrin) and fluorescein isothiocyanate-labeled Fab fragments of goat antireceptor IgG preparation (FITC-Fabantitransferrin receptor antibody). Because the antireceptor antibody and transferrin bind to different sites on the transferrin receptor molecule it was possible to simultaneously and independently follow ligand and receptor. At 4°C, the binding of TRITC-transferrin or FITC-Fab antitransferrin receptor antibody exhibited diffuse membrane fluorescence. At 20°C, the binding of TRITC-transferrin was followed by the rapid formation of aggregates. However, the FITC-Fab antitransferrin receptor did not show similar aggregation at 20°C unless transferrin was present. In the presence of transferrin, the FITC-Fab antitransferrin receptor antibody formed aggregates at the same sites and within the same time period as TRITC transferrin, indicating co-migration. Although the diffuse surface staining of either label was removed by proteolysis, the larger aggregates were not susceptible to enzyme degradation, indicating that they were intracellular. The internal location of the aggregates was also demonstrated using permeabilized cells that had been preincubated with transferrin and fixed with 4% paraformaldehyde. These cells showed aggregated receptor in the interior of the cell when reacted with fluorescein-labeled antibody to the receptor. This indicated that the transferrin and the transferrin receptor co-internalize and migrate to the same structures within the cell.
Transferrin, an iron-binding serum protein, and its receptor on the plasma membrane are considered to be involved in a major pathway for the transport of iron into cells. Superficially, the receptor appears to act as a cation transporter; however, the detailed mechanism of the cellular internalization of iron is still unclear. Initial studies using ~3q-labeled transferrin and cell fractionation found transferfin on the surface of reticuiocytes (l). In more recent work, using ascites tumor cells, ferrocyanide staining of transferrin and ferritinconjugated antibody to transferrin also showed that transferfin is localized on the cell surface (2) . In contrast, there is evidence that transferrin is pinocytosed into reticulocytes and normoblasts (3) (4) (5) . In these studies, ferritin-conjugated antibodies to transferrin (3, 4) and transferrin-colloidal gold complexes (5) were employed to visualize the localization of transferrin.
Experiments demonstrating that transferrin co-purifies with clathrin in h u m a n placental tissues (6, 7) imply that the mechanism of transferrin uptake into cells might be similar to that of many peptides, i.e., asialoglycoprotein receptor, yolk proteins, a-2 macroglobulin, and the hormones, insulin and epidermal growth factor (8, 9) . Many studies of receptormediated endocytosis have been reported (10) (11) (12) (13) (14) (15) . In most of these cases, receptor internalization has been inferred, and only ligand internalization has been directly observed. Protease digestion of the cell surface or treatment with agents that destroyed ligand binding to its receptor was used in some of these studies to suggest that ligand internalization was receptor mediated.
Our study's purpose was to directly observe both the receptor and transferrin following the binding of the ligand to the receptor. In these studies, we fluorescently labeled transferrin and an antibody to the transferrin receptor to visually study them independently on the surface of K562 cells, a human erythroid cell line.
MATERIALS AND METHODS

Generation of Fab Fragments from IgG: Fab fragments of an
IgG preparation of goat anti-human transferrin receptor in which all crossreactivity with transferrin was eliminated (16) were prepared by digesting the antibody (6.8 mg/ml) with papain (0.12 mg/ml; Boehringer Mannheim Biochemicals, Indianapolis, IN) in 0.05 M Tris-HCl, 2 mM EDTA, l mM dithiothreitol, pH 7.4, for 6 h at 37"C. The digested material was loaded onto a Protein A column (Pharmacia Fine Chemicals, Piscataway, N J) equilibrated with 0.01 M Tris-HCI, pH 7.4, and the void volume collected. This material was judged to be free of intact heavy chain by SDS 14% polyacrylamide electrophoresis under reducing conditions (17) .
Fluorochrome Labeling of fab Antitransferrin Receptor and
Transferrin: The purified Fab fragment of the antibody to the human transferrin receptor was labeled with fluorescein isothiocyanate (FITC) t (Sigma Chemical Co.; St. Louis, MO) in 1 M sodium bicarbonate, pH 9.5, for 1 h at room temperature. Unreacted FITC was removed by G-25 gel filtration (Pbarmacia Fine Chemicals) in phosphate-buffered saline (0.01 M sodium phosphate, 0.15 M NaC1, pH 7.4 [PBS]). Iron-saturated human transferrin (Sigma Chemical Co.) was labeled with 50 ~1 of tetramethylrhodamine isothiocyanate (2 mg/ ml dissolved in acetone) (Nordic Immunology, London) in 1 ml of I M sodium bicarbonate at pH 9.5 for 3 h at room temperature. Excess tetramethylrhodamine isothiocyanate (TRITC) was removed by G25 (Pharmacia Fine Chemicals) gel filtration in PBS.
Incubation of Cells with Antibodies and Transferrin: K562
cells were washed twice with PBS and resuspended to 2 x l& cells/ml in PBS with 1 mg/ml ovalbumin. FITC-labeled transferrin and/or TRITC-labeled Fab fragment of antitransferrin receptor were added and incubated at 4"C for 15 min. The cells were then pelleted, washed, and resuspended to 1 x 107 cells/ml in PBS with 1 mg/ml ovalbumin. Samples were stored on ice (15 min) until observed or photographed under a fluorescence microscope. Samples (10 ~1) were dropped on slides, and a cover slip was placed over the sample. Ceils were either taken dimztly from the ice at 4"C and counted or photographed within 5 min, or else were allowed to warm to room temperature either on the slide (5-10 min) or in the incubation tube (30 min) and then counted or photographed.
Anti-human giycophorin generated in goats was a gift of Dr. Leif C. Andersson (18) . FITC-labeled rabbit anti sheep IgG (Antibodies Inc., Davis, CA) was used as a second-step antibody to visualize glycophorin bound to cells. FITC-labeled rabbit anti sheep IgG did not show any fluorescence when incubated by itself with the ceils.
Protease Digestion of Cell Surface Proteins: Cells (1 x 10 6 cells/ml) labeled with fluorescent probes were prepared as described in the previous section, except that ovalbumin was omitted from the buffer in the final wash. Samples were warmed to room temperature and either immediately digested with Streptomyces greiseus protease (500/~g) (Sigma Chemical Co.) or allowed to incubate for 15 or 30 min at room temperature before protease digestion. The digestion was carried out for 5 min at room temperature. Ovalbumin ( I mg) was added, the cells were cooled to 4"C, and washed with PBS containing l mg/ml ovalbumin. Cell viability was 80-96% judged by trypan blue staining.
Fixation of Cells: Cells (5 x 106) were washed free of growth media with PBS, resuspended with 0. l ml of the buffer, and fixed for 5 min at 4"C with a freshly prepared 4% paraformaldehyde isotonic phosphate-buffered solution according to the method of McDowell and Trump (19) . After spinning at 1,000 g for 3 min, they were resuspended immediately in RPMI 1640, 10 mM sodium MOPS, pH 7.5, l mg/ml ovalbumin to stop further fixation. and TRITC, tetramethylrhodamine isothiocyanate.
RESULTS
Time Course and Temperature-dependence of the Internalization of Transferrin and Its Receptor
RAPID COMMUNICATIONS
perature, cells incubated with TRITC-transferrin showed a transition from diffuse membrane fluorescence to brightly fluorescent patches (Fig. 1A) . After 30 min at room temperature, the diffuse fluorescence diminished with coalescence of patches into aggregates (Fig. 1 C) . By contrast, cells incubated with FITC-Fab antitransferrin receptor antibody in the absence of transferrin did not show the same pattern of fluorescence. The fluorescence remained diffuse and showed essentially no patching at room temperature (Fig. IB) . Incubation simultaneously with both fluorescent labels showed co-migration, co-patching, and co-coalescing of TRITC-transferrin and FITC-Fab antitransferrin receptor antibody (Figs. 1, C and D). Table I summarizes the percentage of the cells showing these transitions. It was necessary to use a monovalent Fab fragment of the antitransferrin receptor antibody to show this phenomenon. If purified whole IgG from the antiserum was labeled with FITC and incubated with cells, then the same patterns of aggregation were seen with or without transferrin (Fig. 2, A , B, and C).
Glycophorin Does Not Co-migrate with Transferrin and Its Receptor
We wanted to test whether the aggregation of the receptor/ transferrin complex is restricted to these two proteins or whether all the proteins on the surface of the K562 cells comigrate. Cells incubated at room temperature in the presence of TRITC-transferrin and goat antiglycophorin (an antibody to a protein specific for the erythrocyte membrane) and FITClabeled rabbit anti-goat IgG or all reagents together showed different membrane fluorescence patterns (Fig. 3, A and B) . The TRITC-transferrin exhibited patches identical to those seen in Fig. 1 . The fluorescence detected with goat antiglycophorin and FITC anti-goat IgG did not coaggregate with the transferrin and remained as diffuse stippled fluorescence.
Susceptibility of TRITC-Transferrin and FITC-Fab Antitransferrin Receptor Antibody Binding to Protease Treatment
To determine whether the patched fluorescence represented internalized ligand and receptor, we tested the susceptibility of the fluorescence of each to proteolysis. When cells were incubated for 15 min at 4"C with either TRITC transferrin or FITC-Fab antitransferrin receptor antibody, or both labels, then washed and digested for 5 min with protease, no fluorescence could be detected. However, when cells were incubated at room temperature for 15 min so that both diffuse and patched fluorescence were present (Fig. 4, A and B) , and then incubated for 5 min with protease, only the diffuse fluorescence was susceptible to proteolytic attack. Thus, the patched fluorescence was unavailable to proteolysis (Fig. 4, C and D) .
Fluorescent Patterns of Fixed Cells
The results of the kinetic observations of the unfixed cells indicated that transferrin and the antibody to the transferrin receptor co-migrated to the cell interior, forming a fluorescent aggregate. Because neither of these probes, antibody or transferrin, is covalently bound to the receptor, we wanted to determine whether the receptor was actually located in the same aggregates in which the transferrin migrates or whether the receptor was located elsewhere in the cell. To examine this possibility, cells were preincubated with TRITC-transfer- fin, fixed with paraformaldehyde, and then incubated with the FITC-labeled antibody to the receptor. The results are shown in Fig. 5 . Preincubation of the cells with TRITCtransferrin at room temperature for 15 min followed by fixation (Fig. 5 , B and D) shows patterns of diffuse and patched fluorescence similar to those of unfixed cells incubated for comparable time periods at room temperature (Figs. 1 C, 3A, and 4B). Addition of the FITC-labeled antireceptor antibody after fixation and permeabilization of the cells shows that this antibody reacts at the same intracellular site in which the TRITC-transferrin is localized (Fig. 5) . If the cells are not permeabilized, then the antibody does not have access to these aggregates (Fig. 5 C) and only very diffuse surface fluorescence can be seen. This antibody had been previously absorbed against transferrin to eliminate any crossreactivity with transferrin (16) . These results again indicate that the aggregates or vesicles are located internally.
D I S C U S S I O N
Using TRITC-transferrin, we studied the process oftransferrin binding and internalization in K562 cells. In addition, the transferrin receptor has been independently observed using an FITC Fab fragment of an anti-human transferrin receptor antibody generated in a goat. In a previous paper we demonstrated that transferrin does not compete with the binding of this antibody to the receptor (16) . This enabled us to observe the receptor and transferrin independently and simultaneously. These experiments provide direct evidence for the internalization of transferrin in association with its receptor. van Renswoude et al. (20) have noted that transferrin is internalized in K562 cells. They used fluorescently labeled transferrin and low pH washes to remove surface-bound transferrin. We have shown that, in addition to the transferrin being internalized, the receptor co-internalizes in the same structure. A summary schematic of the events associated with transferrin internalization is presented in Fig. 6 . When transferrin was initially bound at 4°C it exhibited diffuse fluorescence at the cell surface, and, after the cells were brought to room temperature, there were, first, clustering and, then, aggregation of the fluorescence. There was also a loss of susceptibility of the aggregated fluorescence to proteolytic digestion. This is presumably because the transferrin has accumulated within intracellular aggregates.
An interesting finding was the demonstration that the monovalent Fab fragment of the antibody to human transferrin receptor did not internalize and migrate to the cell interior in the absence of transferrin. In the presence of transferrin it comigrated to the cell interior forming a fluorescent aggregate. Transferrin may cause clustering and internalization of the FIGURE 5 Fluorescent patterns of cells fixed in 4% paraformaldehyde. Cells were preincubated for 15 min at room temperature with TRITC-transferrin (2 x 10 -7 M). They were then washed and fixed as described in Materials and Methods. This was followed by incubation with FtTC-antitransferrin receptor for 10 min at room temperature in PBS, 1 mg/ml ovalbumin, and 0.2% Triton X-100 to permeabilize the cells. The same field of cells is seen under fluoroscein fluorescence (A), rhodamine fluorescence (B). The same experiment as described above was repeated but this time, after fixation, the cells were incubated with FITC-antitransferrin receptor antibody in the same buffer lacking 0.2% Triton X-100. C shows fluorescein fluorescence due to FITC-antitransferrin receptor antibody. D shows rhodamine fluorescence due to TRITC-transferrin. x 400.
receptor by inducing a conformational change in the receptor molecule. Alternatively, transferrin binding may act to crosslink receptors close together, as a necessary step for internalization. Perhaps, the bifunctional nature of the two ferric ionbinding sites of the transferrin polypeptide chains is related to this cross-linking function. The experiments with the intact IgG preparation of the antibody to the receptor showed internalization without transferrin being present. However, this is still consistent with a requirement for cross-linking of receptors by a binding agent since the IgG is bivalent.
In addition to the time-course studies showing co-migration, we have shown with fixed cells that the receptor for transferrin can be found in the same intracellular aggregate as previously internalized TRITC-transferrin. The internal location of the aggregate was demonstrated by the need to have Triton X-100 in the incubation buffer for the antireceptor antibody to gain access to this structure. This phenomenon was specific to transferrin and its receptor because control
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RAPID COMMUNICATIONS experiments using antibody to a different membrane antigen, glycophorin, did not show co-internalization. This observation that transferrin does not cause the aggregation of another major cell surface protein, glycophorin, is in agreement with the experiments of Ciehanover et al. (21), who demonstrated that the internalization and recycling of the asialoglycoprotein receptor in a human hepatoma cell line is independent of the transferrin receptor. Thus it appears to be a very specific process.
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